News

Biosense Webster was deemed to have violated antitrust laws by withholding clinical support to hospitals using Innovative’s ...
Researchers at the University of Bath in the UK have developed a wearable belt-like device that can continuously scan the ...
Intravascular lithotripsy is quickly gaining the attention of the medtech industry’s giants. Yet distinguishing its true clinical promise from the financial buzz is no easy task.
Scientists from Kaunas University of Technology (KTU), Lithuania, have developed a system for integrated post-stroke ...
British healthtech company Huma Therapeutics has partnered with Eckuity Capital to lay the foundations for an ‘aggressive’ ...
The FDA has awarded 510(k) clearance to Fujirebio’s Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio in vitro diagnostic (IVD ...
GE HealthCare has gained 501(k) clearance from the US Food and Drug Administration (FDA) for its CleaRecon DL technology.
Implantable lens developer STAAR will fund the repurchase using cash on hand and money generated from business operations.
Ophthalmic technology developer Intalight has received the CE mark for its DREAM OCT (optical coherence tomography) platform ...
OncoHost has won a €2.5m ($2.8m) grant to develop a novel biomarker capable of predicting cancer patient responses to immunotherapy.
Abbott's REFLECT studies indicate that FreeStyle Libre use is linked to a decrease in hospitalisation risk for heart ...
Artificial Intelligence (AI) is now used throughout clinical trials, from recruitment to analysis – but are regulators ...